Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
PMID 22094553
The anticancer effect of EVO in human colon cancer has also been demonstrated, an effect that is partly attributed to its downregulation of Hypoxia-inducible factor 1-alpha (HIF-1) in cancer cells through inhibition of IGF-1/PI3K/Akt signaling (Huang et al., 2015)
This applies to all TRICARE plans (Prime, Select, For Life) and all beneficiaries
Description Additional information Description FOXO4-DRI Peptide Vial **Important Information: Each peptide comes lyophilized/freeze-dried and must be reconstituted with Bacteriostatic Water in order to be dispensable in liquid form
Odogwu and Rao
Patients should discuss any mood changes with their doctors
US$ 24.68
US$ 24.25
US$ 23.37
